Achilles Therapeutics (ACHL) Earnings Date, Estimates & Call Transcripts → After Conviction, More Bad News for Trump (From Paradigm Press) (Ad) Free ACHL Stock Alerts $0.90 0.00 (0.00%) (As of 06/7/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 2EstimatedActual EPS (May. 8) -$0.30 Beat By $0.16 Consensus EPS (May. 8) -$0.46 Get Achilles Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ACHL and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueACHL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ACHL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressAfter Conviction, More Bad News for TrumpAs a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown.Click here to see the details because this coming election meltdown could trigger… Achilles Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.38)($0.38)($0.38)Q2 20241($0.38)($0.38)($0.38)Q3 20241($0.39)($0.39)($0.39)Q4 20241($0.39)($0.39)($0.39)FY 20244($1.54)($1.54)($1.54)ACHL Earnings Date and InformationAchilles Therapeutics last issued its quarterly earnings results on May 8th, 2024. The reported ($0.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.46) by $0.16. Achilles Therapeutics has generated ($1.60) earnings per share over the last year (($1.60) diluted earnings per share). Earnings for Achilles Therapeutics are expected to decrease in the coming year, from ($1.26) to ($1.32) per share. Achilles Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 2nd, 2024 based off prior year's report dates.Read More Achilles Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/2/2024(Estimated)------- 5/8/2024Q1 2024($0.46)($0.30)+$0.16($0.30)--4/4/2024Q4 2023-($0.46)($0.46)($0.46)--11/13/2023Q3 2023($0.38)($0.42)($0.04)($0.42)--8/4/2023Q2 2023($0.40)($0.42)($0.02)($0.42)-- 5/10/2023Q1 2023($0.41)($0.44)($0.03)($0.44)--3/7/2023Q4 2022($0.42)($0.61)($0.19)($0.61)-- Get the Latest News and Ratings for ACHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/8/2022Q3 2022($0.55)($0.32)+$0.23($0.32)--8/9/2022Q2 2022($0.57)($0.44)+$0.13($0.44)--5/10/2022Q1 2022($0.51)($0.45)+$0.06($0.45)--3/1/2022Q4 2021($0.39)($0.45)($0.06)($0.45)--11/8/2021Q3 2021($0.48)($0.34)+$0.14($0.34)-- 8/9/2021Q2 2021($0.53)($0.45)+$0.08($0.45)--5/10/2021Q1 2021($0.94)($8.38)($7.44)($8.38)-- Achilles Therapeutics Earnings - Frequently Asked Questions When is Achilles Therapeutics's earnings date? Achilles Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 2nd, 2024 based off last year's report dates. Learn more on ACHL's earnings history. Did Achilles Therapeutics beat their earnings estimates last quarter? In the previous quarter, Achilles Therapeutics (NASDAQ:ACHL) reported ($0.30) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.46) by $0.16. Learn more on analysts' earnings estimate vs. ACHL's actual earnings. How much profit does Achilles Therapeutics generate each year? Achilles Therapeutics (NASDAQ:ACHL) has a recorded net income of -$69.67 million. ACHL has generated -$1.60 earnings per share over the last four quarters. What is Achilles Therapeutics's EPS forecast for next year? Achilles Therapeutics's earnings are expected to decrease from ($1.26) per share to ($1.32) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CLLS Earnings Results MOLN Earnings Results VXRT Earnings Results CRDF Earnings Results LIFE Earnings Results SGMO Earnings Results DBVT Earnings Results BLUE Earnings Results OMGA Earnings Results ATHA Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:ACHL) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWe’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How)Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from the...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achilles Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.